Statistics

Participants

Total participants

63

Submissions

Total submissions to the Open Development Phase Recurrence phase

22

Total submissions to the Open Development Phase Survival phase

10

Total submissions to the Closed Testing Phase Recurrence phase

6

Total submissions to the Closed Testing Phase Survival phase

5